Michael DesJardin's most recent trade in Horizon Therapeutics Plc was a trade of 3,629 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 2, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2023 | 3,629 | 0 | - | - | Stock Option (Right to Buy) | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.93 per share. | 02 Mar 2023 | 3,629 | 125,815 (0%) | 0% | 14.9 | 54,181 | Ordinary Shares |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.19 per share. | 02 Mar 2023 | 743 | 126,558 (0%) | 0% | 17.2 | 12,772 | Ordinary Shares |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2023 | 743 | 0 | - | - | Stock Option (Right to Buy) | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2023 | 54,253 | 149,087 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 113.24 per share. | 04 Jan 2023 | 26,901 | 122,186 (0%) | 0% | 113.2 | 3,046,269 | Ordinary Shares |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 20,697 | 20,697 | - | - | Restricted Stock Units (RSUs) | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2023 | 12,095 | 0 | - | - | Restricted Stock Units (RSUs) | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2023 | 10,482 | 5,236 | - | - | Performance Restricted Stock Units (PSUs) | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2023 | 10,478 | 10,479 | - | - | Restricted Stock Units (RSUs) | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2023 | 7,257 | 0 | - | - | Performance Restricted Stock Units (PSUs) | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2023 | 7,141 | 14,283 | - | - | Restricted Stock Units (RSUs) | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2023 | 4,834 | 0 | - | - | Performance Restricted Stock Units (PSUs) | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2023 | 1,966 | 0 | - | - | Performance Restricted Stock Units (PSUs) | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2023 | 21,772 | 0 | - | - | Performance Restricted Stock Units (PSUs) | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2023 | 21,772 | 104,395 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 113.80 per share. | 01 Jan 2023 | 9,561 | 94,834 (0%) | 0% | 113.8 | 1,088,042 | Ordinary Shares |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Dec 2022 | 21,772 | 21,772 | - | - | Performance Restricted Stock Units (PSUs) | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Dec 2022 | 15,718 | 15,718 | - | - | Performance Restricted Stock Units (PSUs) | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Dec 2022 | 277 | 82,623 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Sale of securities on an exchange or to another person at price $ 113.60 per share. | 12 Apr 2022 | 11,064 | 82,346 (0%) | 0% | 113.6 | 1,256,870 | Ordinary Shares |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Sale of securities on an exchange or to another person at price $ 112.55 per share. | 12 Apr 2022 | 9,150 | 93,410 (0%) | 0% | 112.6 | 1,029,833 | Ordinary Shares |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Sale of securities on an exchange or to another person at price $ 97.05 per share. | 02 Mar 2022 | 21,482 | 116,078 (0%) | 0% | 97.0 | 2,084,828 | Ordinary Shares |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Sale of securities on an exchange or to another person at price $ 97.42 per share. | 02 Mar 2022 | 13,518 | 102,560 (0%) | 0% | 97.4 | 1,316,924 | Ordinary Shares |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2022 | 3,679 | 0 | - | - | Restricted Stock Units (RSUs) | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2022 | 3,679 | 139,385 (0%) | 0% | 0 | Ordinary Shares | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.42 per share. | 21 Jan 2022 | 1,825 | 137,560 (0%) | 0% | 86.4 | 157,717 | Ordinary Shares |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2022 | 53,734 | 144,681 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.84 per share. | 04 Jan 2022 | 41,276 | 135,706 (0%) | 0% | 101.8 | 4,203,548 | Ordinary Shares |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 32,301 | 176,982 (0%) | 0% | 0 | Ordinary Shares | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 21,424 | 21,424 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2022 | 12,261 | 0 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2022 | 12,095 | 12,095 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2022 | 10,478 | 20,957 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2022 | 9,678 | 4,834 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2022 | 9,222 | 9,223 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2021 | 14,514 | 14,514 | - | - | Performance Restricted Stock Units (PSUs) | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2021 | 7,257 | 94,544 (0%) | 0% | 0 | Ordinary Shares | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.50 per share. | 28 Jul 2021 | 3,599 | 90,945 (0%) | 0% | 102.5 | 368,898 | Ordinary Shares |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Sale of securities on an exchange or to another person at price $ 95.00 per share. | 24 Feb 2021 | 10,786 | 92,504 (0%) | 0% | 95 | 1,024,670 | Ordinary Shares |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Sale of securities on an exchange or to another person at price $ 87.20 per share. | 24 Feb 2021 | 5,158 | 87,346 (0%) | 0% | 87.2 | 449,778 | Ordinary Shares |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Sale of securities on an exchange or to another person at price $ 91.83 per share. | 24 Feb 2021 | 1,099 | 86,247 (0%) | 0% | 91.8 | 100,921 | Ordinary Shares |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2021 | 2,182 | 104,372 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2021 | 2,182 | 0 | - | - | Restricted Stock Units | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.87 per share. | 21 Feb 2021 | 1,082 | 103,290 (0%) | 0% | 88.9 | 96,157 | Ordinary Shares |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 14,512 | 14,512 | - | - | Performance Restricted Stock Units (PSUs) | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 3,931 | 3,931 | - | - | Performance Restricted Stock Units (PSUs) | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 1,965 | 103,165 (0%) | 0% | 0 | Ordinary Shares | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.17 per share. | 17 Feb 2021 | 975 | 102,190 (0%) | 0% | 87.2 | 84,991 | Ordinary Shares |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 11 Feb 2021 | 10,786 | 101,200 (0%) | 0% | 90 | 970,740 | Ordinary Shares |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Sale of securities on an exchange or to another person at price $ 85.00 per share. | 02 Feb 2021 | 4,530 | 111,986 (0%) | 0% | 85 | 385,050 | Ordinary Shares |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2021 | 3,678 | 3,679 | - | - | Performance Restricted Stock Units (PSUs) | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2021 | 3,678 | 118,340 (0%) | 0% | 0 | Ordinary Shares | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.43 per share. | 21 Jan 2021 | 1,824 | 116,516 (0%) | 0% | 77.4 | 141,232 | Ordinary Shares |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Sale of securities on an exchange or to another person at price $ 75.00 per share. | 06 Jan 2021 | 27,106 | 114,662 (0%) | 0% | 75 | 2,032,950 | Ordinary Shares |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2021 | 17,081 | 743 | - | - | Stock Option (Right to Buy) | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.19 per share. | 06 Jan 2021 | 17,081 | 141,768 (0%) | 0% | 17.2 | 293,622 | Ordinary Shares |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2021 | 10,025 | 3,629 | - | - | Stock Option (Right to Buy) | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.93 per share. | 06 Jan 2021 | 10,025 | 124,687 (0%) | 0% | 14.9 | 149,673 | Ordinary Shares |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 60,313 | 165,320 (0%) | 0% | 0 | Ordinary Shares | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.10 per share. | 04 Jan 2021 | 50,658 | 114,662 (0%) | 0% | 36.1 | 1,828,754 | Ordinary Shares |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 41,615 | 105,007 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 31,435 | 31,435 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 17,260 | 0 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 12,261 | 12,261 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 12,094 | 24,190 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Sale of securities on an exchange or to another person at price $ 69.64 per share. | 10 Dec 2020 | 5,909 | 63,392 (0%) | 0% | 69.6 | 411,503 | Ordinary Shares |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2020 | 5,861 | 72,207 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2020 | 5,861 | 0 | - | - | Restricted Stock Units | |
| Horizon Therapeutics Plc | Michael DesJardin | EVP, Technical Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.72 per share. | 05 Dec 2020 | 2,906 | 69,301 (0%) | 0% | 71.7 | 208,418 | Ordinary Shares |